FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079482093> ?p ?o ?g. }

• W2079482093 endingPage "180" @default.
• W2079482093 startingPage "168" @default.
• W2079482093 abstract "Combinations of new medications or existing therapies are gaining momentum over monotherapy to treat central nervous system (CNS) demyelinating diseases including multiple sclerosis (MS). Recent studies established that statins (HMG-CoA reductase inhibitors) are effective in experimental autoimmune encephalomyelitis (EAE), an MS model and are promising candidates for future MS medication. Another drug, rolipram (phosphodiesterase-4 inhibitor) ameliorates the clinical severity of EAE via induction of various anti-inflammatory and neuroprotective activities. In this study, we tested whether combining the suboptimal doses of these drugs can suppress the severity of EAE. Prophylactic studies revealed that combined treatment with suboptimal doses of statins perform better than their individually administered optimal doses in EAE as evidenced by delayed clinical scores, reduced disease severity, and rapid recovery. Importantly, combination therapy suppressed the progression of disease in an established EAE case via attenuation of inflammation, axonal loss and demyelination. Combination treatment attenuated inflammatory TH1 and TH17 immune responses and induced TH2-biased immunity in the peripheral and CNS as revealed by serological, quantitative, and immunosorbant assay-based analyses. Moreover, the expansion of T regulatory (CD25+/Foxp3+) cells and self-immune tolerance was apparent in the CNS. These effects of combined drugs were reduced or minimal with either drug alone in this setting. In conclusion, our findings demonstrate that the combination of these drugs suppresses EAE severity and provides neuroprotection thereby suggesting that this pharmacological approach could be a better future therapeutic strategy to treat MS patients." @default.
• W2079482093 created "2016-06-24" @default.
• W2079482093 creator A5022548683 @default.
• W2079482093 creator A5032747758 @default.
• W2079482093 creator A5073451355 @default.
• W2079482093 creator A5091559034 @default.
• W2079482093 date "2008-12-01" @default.
• W2079482093 modified "2023-09-24" @default.
• W2079482093 title "Combined medication of lovastatin with rolipram suppresses severity of experimental autoimmune encephalomyelitis" @default.
• W2079482093 cites W1676529079 @default.
• W2079482093 cites W1790645982 @default.
• W2079482093 cites W1964937686 @default.
• W2079482093 cites W1965533220 @default.
• W2079482093 cites W1975929837 @default.
• W2079482093 cites W1980857453 @default.
• W2079482093 cites W1985031528 @default.
• W2079482093 cites W1985442646 @default.
• W2079482093 cites W1985829328 @default.
• W2079482093 cites W1990410752 @default.
• W2079482093 cites W1994093380 @default.
• W2079482093 cites W2000811841 @default.
• W2079482093 cites W2001118602 @default.
• W2079482093 cites W2004003727 @default.
• W2079482093 cites W2005329028 @default.
• W2079482093 cites W2006028058 @default.
• W2079482093 cites W2006819998 @default.
• W2079482093 cites W2009161521 @default.
• W2079482093 cites W2010453211 @default.
• W2079482093 cites W2012636039 @default.
• W2079482093 cites W2014218783 @default.
• W2079482093 cites W2016413004 @default.
• W2079482093 cites W2017885661 @default.
• W2079482093 cites W2019582599 @default.
• W2079482093 cites W2029828395 @default.
• W2079482093 cites W2042141510 @default.
• W2079482093 cites W2043379639 @default.
• W2079482093 cites W2043683714 @default.
• W2079482093 cites W2053066468 @default.
• W2079482093 cites W2053714231 @default.
• W2079482093 cites W2058278682 @default.
• W2079482093 cites W2061919041 @default.
• W2079482093 cites W2067397219 @default.
• W2079482093 cites W2074996264 @default.
• W2079482093 cites W2078013635 @default.
• W2079482093 cites W2080324970 @default.
• W2079482093 cites W2084604930 @default.
• W2079482093 cites W2091655047 @default.
• W2079482093 cites W2092830773 @default.
• W2079482093 cites W2099188869 @default.
• W2079482093 cites W2100839274 @default.
• W2079482093 cites W2103097226 @default.
• W2079482093 cites W2110898104 @default.
• W2079482093 cites W2115130178 @default.
• W2079482093 cites W2118140057 @default.
• W2079482093 cites W2122646957 @default.
• W2079482093 cites W2124742434 @default.
• W2079482093 cites W2128867995 @default.
• W2079482093 cites W2129363649 @default.
• W2079482093 cites W2136622296 @default.
• W2079482093 cites W2139908772 @default.
• W2079482093 cites W2145859941 @default.
• W2079482093 cites W2147292685 @default.
• W2079482093 cites W2154022519 @default.
• W2079482093 cites W2155440953 @default.
• W2079482093 cites W2158405641 @default.
• W2079482093 cites W2164508592 @default.
• W2079482093 cites W2164945201 @default.
• W2079482093 cites W2167203210 @default.
• W2079482093 cites W2176744910 @default.
• W2079482093 cites W4229932900 @default.
• W2079482093 doi "https://doi.org/10.1016/j.expneurol.2008.07.024" @default.
• W2079482093 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2636204" @default.
• W2079482093 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18775426" @default.
• W2079482093 hasPublicationYear "2008" @default.
• W2079482093 type Work @default.
• W2079482093 sameAs 2079482093 @default.
• W2079482093 citedByCount "35" @default.
• W2079482093 countsByYear W20794820932012 @default.
• W2079482093 countsByYear W20794820932013 @default.
• W2079482093 countsByYear W20794820932014 @default.
• W2079482093 countsByYear W20794820932016 @default.
• W2079482093 countsByYear W20794820932017 @default.
• W2079482093 countsByYear W20794820932019 @default.
• W2079482093 crossrefType "journal-article" @default.
• W2079482093 hasAuthorship W2079482093A5022548683 @default.
• W2079482093 hasAuthorship W2079482093A5032747758 @default.
• W2079482093 hasAuthorship W2079482093A5073451355 @default.
• W2079482093 hasAuthorship W2079482093A5091559034 @default.
• W2079482093 hasBestOaLocation W20794820932 @default.
• W2079482093 hasConcept C181199279 @default.
• W2079482093 hasConcept C203014093 @default.
• W2079482093 hasConcept C25498285 @default.
• W2079482093 hasConcept C2776958096 @default.
• W2079482093 hasConcept C2777899865 @default.
• W2079482093 hasConcept C2778486448 @default.
• W2079482093 hasConcept C2779727006 @default.
• W2079482093 hasConcept C2780252810 @default.
• W2079482093 hasConcept C2780640218 @default.

• next